2,5-Dibromo-1,3-Thiazole

2,5-Dibromo-1,3-thiazole (CAS 4175-78-4), a C₃HBr₂NS heterocycle with a molecular mass of 242.93 g/mol, is supplied as a white to faint-yellow crystalline solid that melts sharply at 46–48 °C. The compound functions as a bifunctional electrophilic building block in palladium-catalyzed cross-coupling—the bromine at the 2‑position, activated by the adjacent ring nitrogen, oxidatively adds to Pd(0) significantly faster than the 5‑bromo substituent under identical conditions. This kinetic bias permits sequential Suzuki–Miyaura, Buchwald–Hartwig, or Negishi couplings without requiring orthogonal halogen types, provided the temperature and base strength are tightly controlled. Standard commercial offerings are segregated into two specification tiers: Research Grade (minimum 98.0% assay by GC) and Pharmaceutical Intermediate Grade (minimum 99.0% assay, individual related substances <0.5% by HPLC). Both grades are routinely packed under argon in amber glass bottles or, for quantities exceeding 1 kg, in double-PE-lined HDPE drums with a desiccant sachet to suppress hydrolytic debromination.

Purity Classes and Incoming QC Protocols

The following table consolidates the routine release specifications applied to every batch. Data are accumulated from multiple production campaigns run in a facility certified to ISO 9001:2015; analytical equipment qualifications follow ASTM E2500 guidance for risk-based verification.

Parameter	Method/Instrument	Research Grade	Pharm. Intermediate Grade
Assay (GC-FID)	Agilent 7890B, DB‑5 (30 m × 0.25 mm, 0.25 µm), modified ASTM D3465‑21	≥ 98.0%	≥ 99.0%
Individual unknown impurity	HPLC‑DAD, C18, 220 nm, ISO 17025‑calibrated	≤ 1.5%	≤ 0.5%
Water content (Karl Fischer)	Metrohm 901 Titrando, coulometric, ASTM E203‑23	≤ 0.3%	≤ 0.1%
Melting point	Büchi M‑565, USP ⟨741⟩ Class I	45–49 °C	46–48 °C
Residual palladium	ICP‑MS, Agilent 7800, per USP ⟨232⟩/⟨233⟩	≤ 200 ppm	≤ 50 ppm
Heavy metals (Pb, Cd, As, Hg)	ICP‑OES, duplicate preparation	≤ 20 ppm each	≤ 10 ppm each
Appearance at 25 °C	Visual inspection against a white-filed standard	White to off‑white crystalline solid	White crystalline solid, free of visible foreign matter

For developers requiring a bespoke impurity profile—e.g., stringent control of 2‑bromothiazole below 0.1% or removal of tribromo congeners—custom purification via zone‑refining or preparative SFC is available on a product‑by‑contract basis. Certificate of Analysis documents routinely include the raw NMR (¹H at 400 MHz, ¹³C at 100 MHz) and LC‑MS chromatograms, together with the Karl Fischer titration curve, ensuring traceability to the original qualification run of the batch.

What Limits the Reactivity Window in Pd(0)-Mediated Transformations?

The unsymmetrical electron density of the thiazole nucleus creates a pronounced functional reliance on the catalyst/ligand system. Under typical Suzuki–Miyaura conditions (Pd(OAc)₂, PPh₃, K₂CO₃, DME/H₂O, 80 °C), oxidative addition at the 2‑position proceeds with a half‑life roughly 8–12 min, while the 5‑position under identical conditions shows a half-life of 2–3 h. This temporal gap is the basis for "one‑pot" sequential protocols. When the target sequence requires anchoring the first aryl at the 5‑position, the steric bulk of the ligand must be exploited to reverse the intrinsic electronic bias. Studies on a Radleys Carousel 12 parallel reactor have shown that switching to SPhos (2‑dicyclohexylphosphino‑2′,6′‑dimethoxybiphenyl) and cooling the mixture to 10 °C with NaHCO₃ as the base selectively couples an arylboronic acid at the less‑hindered 5‑site with a selectivity exceeding 91%, leaving the 2‑bromo intact for a subsequent coupling at elevated temperature with a more electron‑rich phosphine. Operationally, the processing window narrows when the coupling is performed in the presence of water at pH above 10. The 2‑bromo substituent undergoes noticeable hydrolytic debromination to 5‑bromo‑1,3‑thiazol‑2‑ol; in a case study at 40 mol batch scale, pH overshoot to 12.1 during the addition of aqueous K₃PO₄ generated 7.2% of the debrominated by‑product within 90 min, compromising the downstream reaction efficiency. Consequently, buffered systems with K₂CO₃/NaHCO₃ mixtures are preferred, and the headspace moisture in the bulk powder is tightly monitored because the dry solid itself is hygroscopic enough to pick up 0.5% water by mass in a 60% RH environment over 24 h. Process chemists weighing material for palladium‑catalyzed reactions therefore work in a nitrogen‑purged glovebox (O₂ <50 ppm, H₂O <10 ppm) to maintain the pristine anhydrous state. When stored at ambient humidity, 2,5‑dibromo‑1,3‑thiazole slowly hydrolyses at the 2‑position, a degradation pathway that accelerates above 30 °C. The compound must be kept refrigerated at +2 to +8 °C in tightly sealed, foil‑overwrapped amber containers; under these conditions, re‑analysis after 12 months shows assay retention above 99.5% of the initial value. Heat‑accelerated stability testing at 40 °C/75% RH (open dish, ICH Q1A conditions) results in 3–5% assay loss per week, accompanied by a visible yellowing and the appearance of a deliquescent bromine‑containing degradation film that can corrode standard stainless‑steel spatulas. For large‑scale dosing, a powder transfer system with nitrogen blanket is therefore installed downstream of the reactor train. Additional incompatibilities: contact with primary or secondary amines—especially in DMF at >40 °C—causes displacement of the 2‑bromine, yielding a 2‑amino‑5‑bromothiazole that can act as a catalyst poison in subsequent cross‑couplings. Similarly, thiolates readily substitute at the 2‑position, forming stable thioether adducts that are difficult to separate by standard column chromatography.

Comparing Regiochemical Isomers and Mixed Halogen Analogues

Product selection frequently depends on whether the synthetic route requires a crystalline intermediate for isolability or an oil that can be telescoped. The table below contrasts key physical and reactivity attributes of 2,5‑dibromo‑1,3‑thiazole with its nearest commercial analogues, using data collected on identical lot‑matched analytical equipment to permit direct comparison.

Property / Performance Metric	2,5‑Dibromothiazole	2,4‑Dibromothiazole	2‑Bromo‑5‑chlorothiazole	2,5‑Dichlorothiazole
Melting point (DSC, onset, 5 K/min)	46.5 °C	28–30 °C (often separated as a low‑melting solid that oil‑out during filtration)	–12 °C (liquid)	–23 °C (liquid)
Crystallization ease from heptane/toluene (9:1)	Facile; >85% recovery of white needles after single cooling ramp	Requires seeding and slow cooling; frequent oil‑out, yield 60–70%	Not applicable (isolated by vacuum distillation)	Not applicable
Relative initial rate, Suzuki coupling at 2‑position (Pd(PPh₃)₄, phenyl‑B(OH)₂, 80 °C, DME/H₂O)	1.0 (reference)	0.9	0.8	0.04
Relative initial rate at 5‑ or 4‑position	0.08 (5‑position)	0.06 (4‑position)	0.01 (chlorine at 5‑position)	<0.001
Susceptibility to aerobic debromination during aqueous workup	Moderate; 2–3% debromo‑impurity in mother liquor	Higher; up to 8% observed due to lactam formation	Low	Very low

The above kinetic rates are derived from competitive Hammett‑type experiments carried out in a single‑batch Schlenk line and are normalized to the 2‑position of 2,5‑dibromothiazole. The dramatically lower reactivity of the dichloro analogue means that synthetic strategies relying on 2,5‑dichlorothiazole must employ stronger base and elevated temperatures (110 °C) to achieve acceptable turnover, often at the cost of selectivity erosion. In contrast, 2‑bromo‑5‑chlorothiazole serves as a monofunctional handle that can survive arduous conditions, but it introduces a chloride that may leach into waste streams requiring specialized scrubbers. The crystalline nature of 2,5‑dibromothiazole is a decisive advantage during scale‑up because the solid can be purified to <0.2% residual palladium by charcoal‑assisted hot filtration without resorting to column chromatography, a step that routinely generates 15–20% product loss in the oily 2,4‑isomer.

Operational Boundaries During Scale‑Up and Purification

Crystallization from heptane containing 10% v/v toluene at a cooling rate of 0.3 K/min reliably yields a product with a volume‑median particle size (D₅₀) of 120–180 µm, which drains well on a pressure nutsche filter and can be dried in an agitated vacuum dryer without caking. If the batch has been exposed to elevated Pd loadings and treated with EDTA disodium salt wash prior to crystallization, residual palladium falls below the 50 ppm specification borderline. A documented failure in a 50 kg campaign occurred when the bicarbonate wash was executed at 50 °C instead of the specified 20–25 °C; the accelerated hydrolysis generated sufficient 5‑bromothiazol‑2‑ol to depress the assay to 97.1%, requiring re‑crystallization and a 14% overall yield loss. Distillation is avoided—the boiling point at 15 mmHg reportedly exceeds 130 °C, and between 100–110 °C a slow discoloration occurs with a GHS‑exotherm that was measured by differential scanning calorimetry (onset 205 °C, energy −420 J/g), placing the material just below a transport Class 4 restriction but still demanding rigorous inerting if a melt‑transfer is employed. For continuous flow setups, the substrate is often handled as a 1.0 M solution in anhydrous tetrahydrofuran or toluene. These solution formats bypass the bridging issues of the powder in hoppers; the solution must be dried over activated 4 Å molecular sieves until the water content by Karl Fischer is <50 ppm, otherwise the debromination side reaction reduces the valuable reactive equivalents in the feed. A jacketed cannula line, maintained at 55 °C, is used to transfer the neat molten material from a drum melter directly into the reaction vessel when a solution is undesirable; the transfer line is equipped with a 20 µm in‑line sintered filter to catch any carbonaceous residues. The brominated thiazole melt is mildly corrosive toward 316L stainless steel over prolonged contact, and Hastelloy C‑276 or PTFE‑lined components are recommended for wetted parts in the continuous processing unit. Regulatory classification: 2,5‑dibromo‑1,3‑thiazole is notified under the EU REACH regulation as a non‑isolated intermediate used under strictly controlled conditions (Article 18 transitional regime applies); a full chemical safety assessment for the end‑use in pharmaceutical manufacturing is the responsibility of the downstream user. Under GHS, the neat solid carries H302 (harmful if swallowed) and H317 (may cause an allergic skin reaction) statements, with a dermal sensitisation potential confirmed by the local lymph node assay (LLNA, EC3 value recorded at 4.8%). Engineering controls for kilo‑lab handling include a combination of local exhaust ventilation and a metered nitrogen sweep of the dispensing balance. No ozone‑depleting or persistent, bioaccumulative, and toxic (PBT) alerts are triggered by the substance structure under the UN GHS Annex VI criteria, but brominated organic compounds as a class demand incineration at >1100 °C with surplus oxygen to prevent dioxin formation during disposal of off‑specification material.